Literature DB >> 28800177

Exercise stress test reveals ineligibility for subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.

Motomi Tachibana1, Nobuhiro Nishii2, Hiroshi Morita2, Koji Nakagawa3, Atsuyuki Watanabe3, Kazufumi Nakamura3, Hiroshi Ito3.   

Abstract

BACKGROUND: The eligibility of patients with Brugada syndrome (BrS) for implantation of a subcutaneous implantable cardioverter defibrillator (S-ICD) is not well known. This study aimed to clarify the eligibility of BrS patients for S-ICD using electrocardiography (ECG) at rest and during exercise testing. We also analyzed factors associated with ineligibility for S-ICD from standard 12-lead ECG at rest.
METHODS: We enrolled 110 consecutive BrS patients who visited Okayama university hospital from December 2015 to December 2016. All patients were assessed for S-ICD eligibility, which required one lead to satisfy the S-ICD screening template. We assessed standard 12-lead ECG parameters in all participants. Of those who passed S-ICD screening, 45 patients were assessed for S-ICD eligibility during treadmill stress test.
RESULTS: Mean age of study patients was 54 ± 13 years and 108 (98%) were men. In total, 89 patients (81%) satisfied S-ICD indications at rest. Existence of complete right bundle branch block (CRBBB) on standard 12-lead ECG was a significant predictor of ineligibility for S-ICD (odds ratio, 5.00; P = 0.03; 95%CI, 1.14-21.98). Of the 45 patients who underwent treadmill stress testing, 11 patients (24%) showed ineligibility for S-ICD during the test.
CONCLUSION: CRBBB was a predictor of ineligibility for S-ICD in patients with BrS. Sinus tachycardia changes ECG morphology in some patients and stress testing should be considered before S-ICD implantation.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Brugada syndrome; exercise stress test; implantable cardioverter defibrillator; inappropriate shock; subcutaneous implantable cardioverter defibrillator

Mesh:

Year:  2017        PMID: 28800177     DOI: 10.1111/jce.13315

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  5 in total

1.  Patient characteristics and in-hospital complications of subcutaneous implantable cardioverter-defibrillator for Brugada syndrome in Japan.

Authors:  Iwanari Kawamura; Mikio Nakajima; Takeshi Kitamura; Richard H Kaszynski; Rintaro Hojo; Hiroyuki Ohbe; Yusuke Sasabuchi; Hiroki Matsui; Kiyohide Fushimi; Seiji Fukamizu; Hideo Yasunaga
Journal:  J Arrhythm       Date:  2019-09-16

2.  Lead-associated Superior Vena Cava Syndrome.

Authors:  Andrew H Locke; David J Shim; Jessica Burr; Tyler Mehegan; Kelsey Murphy; André D'Avila; Marc L Schermerhorn; Peter Zimetbaum
Journal:  J Innov Card Rhythm Manag       Date:  2021-04-15

3.  Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes.

Authors:  Pier D Lambiase; Lars Eckardt; Dominic A Theuns; Timothy R Betts; Andreas L Kyriacou; Elizabeth Duffy; Reinoud Knops
Journal:  Heart Rhythm O2       Date:  2020-10-28

4.  SMART pass will prevent inappropriate operation of S-ICD.

Authors:  Motomi Tachibana; Nobuhiro Nishii; Kimikazu Banba; Shinpei Fujita; Etsuko Ikeda; Keisuke Okawa; Hiroshi Morita; Hiroshi Ito
Journal:  J Arrhythm       Date:  2018-11-20

Review 5.  State-of-the-art consensus on non-transvenous implantable cardioverter-defibrillator therapy.

Authors:  Christoph Schukro; David Santer; Günther Prenner; Markus Stühlinger; Martin Martinek; Alexander Teubl; Deddo Moertl; Stefan Schwarz; Michael Nürnberg; Lukas Fiedler; Robert Hatala; Cesar Khazen
Journal:  Clin Cardiol       Date:  2020-08-14       Impact factor: 2.882

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.